A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants

NCT05445232 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: LY3437943
DRUG: Midazolam
DRUG: Warfarin
DRUG: Caffeine

Sponsor

Eli Lilly and Company